With Covid-19 cases up across the country, many people are once again relying on home tests to guide decisions about going to work and sending their kids to school and other activities. A lot of those ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...
Autonomous Medical Devices Incorporated (AMDI) today announced that the U.S. Food and Drug Administration has granted both ...
The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...
According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers ...
In recent years, point-of-care nucleic acid testing had played an important role in the diagnosis of infectious diseases. Despite its advantages, current point-of-care testing (POCT) platforms were ...
Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved ...
This study elaborates on the design, fabrication, and data analysis details of SPEED, a recently proposed smartphone-based digital polymerase chain reaction (dPCR) device. The dPCR chips incorporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results